Effect of Ultrasound Cavitation on Static and Dynamic Balance in Obese Postnatal Women With Diastasis Recti
1 other identifier
interventional
60
1 country
1
Brief Summary
the aim of this study is to investigate the efficacy of ultrasound cavitation on static and dynamic balance in obese postnatal women with diastasis recti
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 26, 2023
CompletedStudy Start
First participant enrolled
June 9, 2023
CompletedFirst Posted
Study publicly available on registry
June 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 9, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 9, 2023
CompletedAugust 30, 2024
August 1, 2024
4 months
May 26, 2023
August 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Static postural balance
The Biodex Balance System SD (model: TP-3040-15, DC input: 19V-6.32A, connected to computer software version 4.0.06, 2017, serial number: R712010010, made in Taiwan) will be used to measure overall stability index of static postural balance for all patients
up to eight weeks
Dynamic postural balance
The Biodex Balance System SD (model: TP-3040-15, DC input: 19V-6.32A, connected to computer software version 4.0.06, 2017, serial number: R712010010, made in Taiwan) will be used to measure overall stability index of dynamic postural balance for all patients
up to eight weeks
Secondary Outcomes (3)
Abdominal subcutaneous fat thickness
up to eight weeks
Inter recti distance
up to eight weeks
Lumbar lordotic angle
up to eight weeks
Study Arms (2)
low caloric diet regimn
EXPERIMENTALpatients will follow low caloric diet regimn (1600: 2000 Kcal/ day), lipids approximately (20: 35%) of total caloric intake, protein approximately (10: 35%) of total caloric intake and high complexed carbohydrate intake approximately (45: 65%) of total caloric intake (with increased fiber-rich whole grain breads, cereals, fruits and vegetables), for eight weeks.
ultrasound cavitation for 30 minutes, twice per week for eight weeks and low caloric diet regimn
EXPERIMENTALultrasound cavitation, Dae Yang, Mabel 6, frequency (50: 60) Hz, power consumption 150 W, power input AC (100: 230) V, hand probe diameter 8.0 cm, serial number DY73-15037, produced by DAEYANG MEDICAL company, made in Korea. the device will be applied for 30 minutes on the abdominal area, twice per week for eight weeks. low caloric diet regimn patients will follow low caloric diet regimn (1600: 2000 Kcal/ day), lipids approximately (20: 35%) of total caloric intake, protein approximately (10: 35%) of total caloric intake and high complexed carbohydrate intake approximately (45: 65%) of total caloric intake (with increased fiber-rich whole grain breads, cereals, fruits and vegetables), for eight weeks.
Interventions
lipids approximately (20: 35%) of total caloric intake, protein approximately (10: 35%) of total caloric intake and high complexed carbohydrate intake approximately (45: 65%) of total caloric intake (with increased fiber-rich whole grain breads, cereals, fruits and vegetables), for eight weeks.
patients will assume standing position, the abdominal area will be divided vertically into 2 equal sections, right and left segment, extending bilaterally from the line stretching between the mid axilla above and the iliac crest below, and upward from center of diaphragm to the midpoint extending between two iliac crest below, then from supine lying position the cavitation head will be applied on each abdominal segment for 15 minutes with total treatment time 30 minutes twice per week for eight weeks
Eligibility Criteria
You may qualify if:
- All women had a diastasis recti more than 2.5 cm and less than 4 cm in supra umbilical region.
- Their ages were ranged from 25: 35 years.
- Their BMI was more than 30 Kg/ m2.
- All women were with lumbar hyperlordosis.
- All women were multipara.
- Their mode of delivery was normal vaginal delivery.
- They were selected from 2: 5 months postnatal.
You may not qualify if:
- Previous cesarean section.
- Previous abdominal and/ or back operation.
- Spinal disorders.
- Abdominal skin diseases.
- Serious diseases such as heart disease, pace maker, uncontrolled diabetes or hypertension, autoimmune disease, malignancy, gastric ulcer, liver or renal failure and any other contraindication for body sculpting-weight loss.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Asmaa Maher Ahmed Zahran
Giza, 12511, Egypt
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principle investigator
Study Record Dates
First Submitted
May 26, 2023
First Posted
June 13, 2023
Study Start
June 9, 2023
Primary Completion
October 9, 2023
Study Completion
December 9, 2023
Last Updated
August 30, 2024
Record last verified: 2024-08